|
|
|
|
Effects Of Exenatide Plus Rosiglitazone On Beta Cell Function And Insulin Sensitivity In Subjects With Type 2 Diabetes On Metformin
DeFronzo RA et al.Effects Of Exenatide Plus Rosiglitazone On Beta Cell Function And Insulin Sensitivity In Subjects With Type 2 Diabetes On Metformin.
|
|
|
Effects of peroxisome proliferator-activated receptor agonists on Na+ transport and activity of the kinase SGK1 in epithelial cells from lung and kidney
Background and purpose: Peroxisome proliferator-activated receptor [gamma] (PPAR[gamma]) agonists, such as rosiglitazone and pioglitazone, sensitize cells to insulin, and are therefore used to treat type 2 diabetes.However, in some patients, these drugs...
|
|
|
A New Treatment Option For Adults With Type 2 Diabetes
THERE?S IMPORTANT NEWS FOR ADULTS WITH TYPE 2 DIABETES, THE FDA RECENTLY APPROVED A NEW MEDICINE.DANIELLE ADDAIR HAS MORE. STORY INFORMATION: THIS IS A MULTIVU SPECIAL REPORT BROUGHT TO YOU BY BRISTOL-MEYERS SQUIBB AND ASTRAZENECA. DESPITE CURRENT...
|
|
|
Rosiglitazone decreases intra- to extramyocellular fat ratio in obese non-diabetic adults with metabolic syndrome
GodoyMatos AF et al.Rosiglitazone treatment increased body weight and hip circumference and decreased WHR. Rosiglitazone decreases intra- to extramyocellular fat ratio in obese non-diabetic adults with metabolic syndrome.
|
|
|
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes - public
The Journal of Clinical Endocrinology & Metabolism Vol.95, No. 1 134-142 Bernard Zinman, Steven M. Haffner, William H. Herman, Rury R. Holman, John M. Lachin, Barbara G. Kravitz, Gitanjali Paul, Nigel P. Jones, R. Paul Aftring, Giancarlo...
|
|
|
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 year
_ Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 year.
|
|
|
Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats
Hypertension Research advance online publication, January 8, 2010.doi:10. Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats.
|
